KLAYESTA (nystatin topical powder) by Epic Pharma Llc is clinical pharmacology pharmacokinetics klayesta is not absorbed from intact skin or mucous membrane. Approved for the treatment of cutaneous, mucocutaneous mycotic infections caused by candida albicans, other susceptible candida species. First approved in 2018.
Drug data last refreshed 13h ago
CLINICAL PHARMACOLOGY Pharmacokinetics KLAYESTA is not absorbed from intact skin or mucous membrane. Microbiology Nystatin is an antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi, including Candida albicans, C. parapsilosis, C.…
Polyene Antifungal
Worked on KLAYESTA at Epic Pharma Llc? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.